Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

EMEA (Europe, Middle East and Africa) Rapid Influenza Diagnostic Tests Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • Purchase Options

 
In this report, the EMEA Rapid Influenza Diagnostic Tests market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Rapid Influenza Diagnostic Tests for these regions, from 2014 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Rapid Influenza Diagnostic Tests market competition by top manufacturers/players, with Rapid Influenza Diagnostic Tests sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Alere
BD
Quidel
bioMrieux
CorisBioconcept
Meridian Bioscience
Response Biomedical (acquired by OrbiMed)
Princeton BioMeditech Corporation
SA Scientific
Sekisui Diagnostics
Thermo Fisher Scientific

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Influenza A
Influenza B

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Rapid Influenza Diagnostic Tests for each application, including
Hospital
Clinic
Household
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Rapid Influenza Diagnostic Tests Market Report 2019
1 Rapid Influenza Diagnostic Tests Overview
1.1 Product Overview and Scope of Rapid Influenza Diagnostic Tests
1.2 Classification of Rapid Influenza Diagnostic Tests
1.2.1 EMEA Rapid Influenza Diagnostic Tests Market Size (Sales) Comparison by Type (2014-2024)
1.2.2 EMEA Rapid Influenza Diagnostic Tests Market Size (Sales) Market Share by Type (Product Category) in 2018
1.2.3 Influenza A
1.2.4 Influenza B
1.3 EMEA Rapid Influenza Diagnostic Tests Market by Application/End Users
1.3.1 EMEA Rapid Influenza Diagnostic Tests Sales (Volume) and Market Share Comparison by Application (2014-2024
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Other
1.4 EMEA Rapid Influenza Diagnostic Tests Market by Region
1.4.1 EMEA Rapid Influenza Diagnostic Tests Market Size (Value) Comparison by Region (2014-2024)
1.4.2 Europe Status and Prospect (2014-2024)
1.4.3 Middle East Status and Prospect (2014-2024)
1.4.4 Africa Status and Prospect (2014-2024)
1.5 EMEA Market Size (Value and Volume) of Rapid Influenza Diagnostic Tests (2014-2024)
1.5.1 EMEA Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2024)
1.5.2 EMEA Rapid Influenza Diagnostic Tests Revenue and Growth Rate (2014-2024)

2 EMEA Rapid Influenza Diagnostic Tests Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Rapid Influenza Diagnostic Tests Market Competition by Players/Manufacturers
2.1.1 EMEA Rapid Influenza Diagnostic Tests Sales Volume and Market Share of Major Players (2014-2019)
2.1.2 EMEA Rapid Influenza Diagnostic Tests Revenue and Share by Players (2014-2019)
2.1.3 EMEA Rapid Influenza Diagnostic Tests Sale Price by Players (2014-2019)
2.2 EMEA Rapid Influenza Diagnostic Tests (Volume and Value) by Type/Product Category
2.2.1 EMEA Rapid Influenza Diagnostic Tests Sales and Market Share by Type (2014-2019)
2.2.2 EMEA Rapid Influenza Diagnostic Tests Revenue and Market Share by Type (2014-2019)
2.2.3 EMEA Rapid Influenza Diagnostic Tests Sale Price by Type (2014-2019)
2.3 EMEA Rapid Influenza Diagnostic Tests (Volume) by Application
2.4 EMEA Rapid Influenza Diagnostic Tests (Volume and Value) by Region
2.4.1 EMEA Rapid Influenza Diagnostic Tests Sales and Market Share by Region (2014-2019)
2.4.2 EMEA Rapid Influenza Diagnostic Tests Revenue and Market Share by Region (2014-2019)
2.4.3 EMEA Rapid Influenza Diagnostic Tests Sales Price by Region (2014-2019)

3 Europe Rapid Influenza Diagnostic Tests (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Rapid Influenza Diagnostic Tests Sales and Value (2014-2019)
3.1.1 Europe Rapid Influenza Diagnostic Tests Sales Volume and Growth Rate (2014-2019)
3.1.2 Europe Rapid Influenza Diagnostic Tests Revenue and Growth Rate (2014-2019)
3.2 Europe Rapid Influenza Diagnostic Tests Sales and Market Share by Type
3.3 Europe Rapid Influenza Diagnostic Tests Sales and Market Share by Application
3.4 Europe Rapid Influenza Diagnostic Tests Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Rapid Influenza Diagnostic Tests Sales Volume by Countries (2014-2019)
3.4.2 Europe Rapid Influenza Diagnostic Tests Revenue by Countries (2014-2019)
3.4.3 Germany Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)
3.4.4 France Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)
3.4.5 UK Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)
3.4.6 Russia Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)
3.4.7 Italy Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)
3.4.8 Benelux Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)

4 Middle East Rapid Influenza Diagnostic Tests (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Rapid Influenza Diagnostic Tests Sales and Value (2014-2019)
4.1.1 Middle East Rapid Influenza Diagnostic Tests Sales Volume and Growth Rate (2014-2019)
4.1.2 Middle East Rapid Influenza Diagnostic Tests Revenue and Growth Rate (2014-2019)
4.2 Middle East Rapid Influenza Diagnostic Tests Sales and Market Share by Type
4.3 Middle East Rapid Influenza Diagnostic Tests Sales and Market Share by Application
4.4 Middle East Rapid Influenza Diagnostic Tests Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Rapid Influenza Diagnostic Tests Sales Volume by Countries (2014-2019)
4.4.2 Middle East Rapid Influenza Diagnostic Tests Revenue by Countries (2014-2019)
4.4.3 Saudi Arabia Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)
4.4.4 Israel Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)
4.4.5 UAE Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)
4.4.6 Iran Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)

5 Africa Rapid Influenza Diagnostic Tests (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Rapid Influenza Diagnostic Tests Sales and Value (2014-2019)
5.1.1 Africa Rapid Influenza Diagnostic Tests Sales Volume and Growth Rate (2014-2019)
5.1.2 Africa Rapid Influenza Diagnostic Tests Revenue and Growth Rate (2014-2019)
5.2 Africa Rapid Influenza Diagnostic Tests Sales and Market Share by Type
5.3 Africa Rapid Influenza Diagnostic Tests Sales and Market Share by Application
5.4 Africa Rapid Influenza Diagnostic Tests Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Rapid Influenza Diagnostic Tests Sales Volume by Countries (2014-2019)
5.4.2 Africa Rapid Influenza Diagnostic Tests Revenue by Countries (2014-2019)
5.4.3 South Africa Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)
5.4.4 Nigeria Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)
5.4.5 Egypt Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)
5.4.6 Algeria Rapid Influenza Diagnostic Tests Sales and Growth Rate (2014-2019)

6 EMEA Rapid Influenza Diagnostic Tests Manufacturers/Players Profiles and Sales Data
6.1 Alere
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Rapid Influenza Diagnostic Tests Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Alere Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 BD
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Rapid Influenza Diagnostic Tests Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 BD Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Quidel
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Rapid Influenza Diagnostic Tests Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Quidel Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 bioMrieux
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Rapid Influenza Diagnostic Tests Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 bioMrieux Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 CorisBioconcept
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Rapid Influenza Diagnostic Tests Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 CorisBioconcept Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 Meridian Bioscience
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Rapid Influenza Diagnostic Tests Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Meridian Bioscience Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 Response Biomedical (acquired by OrbiMed)
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Rapid Influenza Diagnostic Tests Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Response Biomedical (acquired by OrbiMed) Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
6.8 Princeton BioMeditech Corporation
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Rapid Influenza Diagnostic Tests Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Main Business/Business Overview
6.9 SA Scientific
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Rapid Influenza Diagnostic Tests Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 SA Scientific Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin (2014-2019)
6.9.4 Main Business/Business Overview
6.10 Sekisui Diagnostics
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Rapid Influenza Diagnostic Tests Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Sekisui Diagnostics Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin (2014-2019)
6.10.4 Main Business/Business Overview
6.11 Thermo Fisher Scientific

7 Rapid Influenza Diagnostic Tests Manufacturing Cost Analysis
7.1 Rapid Influenza Diagnostic Tests Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Rapid Influenza Diagnostic Tests

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Rapid Influenza Diagnostic Tests Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Rapid Influenza Diagnostic Tests Major Manufacturers in 2018
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Rapid Influenza Diagnostic Tests Market Forecast (2019-2024)
11.1 EMEA Rapid Influenza Diagnostic Tests Sales, Revenue and Price Forecast (2019-2024)
11.1.1 EMEA Rapid Influenza Diagnostic Tests Sales and Growth Rate Forecast (2019-2024)
11.1.2 EMEA Rapid Influenza Diagnostic Tests Revenue and Growth Rate Forecast (2019-2024)
11.1.3 EMEA Rapid Influenza Diagnostic Tests Price and Trend Forecast (2019-2024)
11.2 EMEA Rapid Influenza Diagnostic Tests Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.3 Europe Rapid Influenza Diagnostic Tests Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.4 Middle Eastt Rapid Influenza Diagnostic Tests Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.5 Africa Rapid Influenza Diagnostic Tests Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.6 EMEA Rapid Influenza Diagnostic Tests Sales Forecast by Type (2019-2024)
11.7 EMEA Rapid Influenza Diagnostic Tests Sales Forecast by Application (2019-2024)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us